Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Finding Immune Nascent Type 1 Diabetes

Key facts

Where
Indianapolis, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 1 and 99 years old?

Source: NCT07663136, who can take part

Where in United States

  • Indiana University School of MedicineIndianapolis, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Indiana University
Trial code
NCT07663136
Record updated
2 October 2026
Original description
The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is:Read full original descriptionShow less

Finding Immune Nascent Type 1 Diabetes (FIND T1D)

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is:

What form of recruitment communication is most effective for completing a type 1diabetes home screening kit?

Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch).

Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.

Inclusion: Participant must be in Indiana Biobank; Participant must be able to provide consent; Ages 1-99 including pregnant women.

Exclusion: While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening; Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study.

ClinicalTrials.gov NCT07663136